Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “STAGE IIIB OR IV NON-SMALL CELL LUNG CANCER”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02949843
What this trial is testing

Targeted Therapy in Treating Patients With Incurable Non-Small Cell Lung Cancer With Genetic Mutations

Who this might be right for
EGFR Activating MutationRecurrent Non-Small Cell Lung CarcinomaStage IV Non-Small Cell Lung Cancer
Wake Forest University Health Sciences 19
Testing effectiveness (Phase 2)Study completedNCT01849250
What this trial is testing

Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivors

Who this might be right for
Benign Breast NeoplasmDuctal Breast Carcinoma In SituInvasive Breast Carcinoma+9 more
National Cancer Institute (NCI) 65
Large-scale testing (Phase 3)Study completedNCT01368276
What this trial is testing

An Extended Use Study of Safety and Efficacy of Talimogene Laherparepvec in Melanoma

Who this might be right for
Melanoma
BioVex Limited 31
Large-scale testing (Phase 3)Study completedNCT00242580
What this trial is testing

A Safety and Efficacy Study Comparing the Combination Treatments of Verteporfin Therapy Plus One of Two Different Doses of Intravitreal Triamcinolone Acetonide and the Verteporfin Therapy Plus Intravitreal Pegaptanib

Who this might be right for
Macular DegenerationChoroidal Neovascularization
Novartis Pharmaceuticals 111
Testing effectiveness (Phase 2)Study completedNCT04776447
What this trial is testing

Atezolizumab Plus Induction Chemotherapy Plus CT-radiotherapy. (APOLO)

Who this might be right for
Lung DiseasesCarcinoma, Non-Small-Cell LungStage IIIA Non-small Cell Lung Cancer+4 more
Fundación GECP 38
Testing effectiveness (Phase 2)UnknownNCT04200040
What this trial is testing

A Clinical Study to Evaluate the Safety and Efficacy of OrienX010 in Unresectable Malignant Melanoma Patients

Who this might be right for
Melanoma (Skin)
OrienGene Biotechnology Ltd. 165
Large-scale testing (Phase 3)UnknownNCT01087268
What this trial is testing

Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients With Pelvic Cancer

Who this might be right for
Bladder CancerCervical CancerColorectal Cancer+9 more
Royal Marsden NHS Foundation Trust 75
Very early researchLooking for participantsNCT05493566
What this trial is testing

Low-Dose Interleukin-2 and Pembrolizumab for the Treatment of Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8Stage IVA Lung Cancer AJCC v8+1 more
Emory University 15
Large-scale testing (Phase 3)Study completedNCT00420745
What this trial is testing

To Assess Safety, Reactogenicity & Immunogenicity of 2 Doses of GSK's Oral Human Rotavirus Vaccine in Pre-Term Infants

Who this might be right for
Infections, Rotavirus
GlaxoSmithKline 1,009
Large-scale testing (Phase 3)Study completedNCT00820755
What this trial is testing

Trial With Cetuximab in Maintenance Therapy After Platinum Based Chemotherapy in First Line Treatment of Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)
Merck KGaA, Darmstadt, Germany 583
Testing effectiveness (Phase 2)UnknownNCT00801385
What this trial is testing

Sorafenib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Chemotherapy

Who this might be right for
Lung Cancer
Yonsei University 47
Testing effectiveness (Phase 2)Study completedNCT00003050
What this trial is testing

Radiation Therapy Plus Paclitaxel in Treating Patients With Stage IIB or Stage III Breast Cancer

Who this might be right for
Breast Cancer
University of Southern California 46
Testing effectiveness (Phase 2)Study completedNCT00233974
What this trial is testing

Molecular Marker Profiling of Axillary Lymph Nodes in Predicting Response in Patients With Locally Advanced or Metastatic Breast Cancer Who Are Undergoing Chemotherapy Followed By Surgery

Who this might be right for
Breast Cancer
UNC Lineberger Comprehensive Cancer Center 15
Testing effectiveness (Phase 2)Ended earlyNCT00526890
What this trial is testing

Carboplatin, Paclitaxel, Selenomethionine, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery

Who this might be right for
Lung Cancer
Roswell Park Cancer Institute 16
Testing effectiveness (Phase 2)Ended earlyNCT02831933
What this trial is testing

Trial of Radiation and Gene Therapy Before Nivolumab for Metastatic Non-Small Cell Lung Carcinoma and Uveal Melanoma

Who this might be right for
Lung Squamous Cell Carcinoma Stage IVNonsquamous Nonsmall Cell Neoplasm of LungMetastatic Uveal Melanoma
Eric Bernicker, MD 11
Not applicableLooking for participantsNCT04907643
What this trial is testing

Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

Who this might be right for
Cancer PainVisceral PainGastrointestinal Neoplasms+76 more
Cedars-Sinai Medical Center 360
Early research (Phase 1)Active Not RecruitingNCT01251874
What this trial is testing

Veliparib and Carboplatin in Treating Patients With HER2-Negative Metastatic Breast Cancer

Who this might be right for
Recurrent Breast CarcinomaStage IIIB Breast Cancer AJCC v7Stage IIIC Breast Cancer AJCC v7+2 more
National Cancer Institute (NCI) 44
Testing effectiveness (Phase 2)WithdrawnNCT02672358
What this trial is testing

Study of Efficacy and Safety of Dabrafenib and Trametinib Combination Therapy in Japanese Patients With BRAF V600E Stage IV NSCLC

Who this might be right for
Non-Small-Cell Lung Cancer
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)UnknownNCT00052325
What this trial is testing

Mistletoe in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Are Receiving Palliative Chemotherapy

Who this might be right for
Lung Cancer
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Early research (Phase 1)Study completedNCT00734890
What this trial is testing

Vandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Lung CancerLymphomaLymphoproliferative Disorder+2 more
National Institutes of Health Clinical Center (CC) 18
Next Page